Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway
Open Access
- 3 June 2015
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 16 (6) , 12482-12498
Abstract
Plasma urotensin II (UII) has been observed to be raised in patients with acute myocardial infarction; suggesting a possible cardiac protective role for this peptide. However, the molecular mechanism is unclear. Here, we treated cultured cardiomyocytes with H2O2 to induce oxidative stress; observed the effect of UII on H2O2-induced apoptosis and explored potential mechanisms. UII pretreatment significantly reduced the number of apoptotic cardiomyocytes induced by H2O2; and it partly abolished the increase of pro-apoptotic protein Bax and the decrease of anti-apoptotic protein Bcl-2 in cardiomyocytes induced by H2O2. SiRNA targeted to the urotensin II receptor (UT) greatly inhibited these effects. Further analysis revealed that UII increased the production of hydrogen sulfide (H2S) and the level of cystathionine-γ-lyase (CSE) by activating the ERK signaling in H2O2-treated-cardiomyocytes. Si-CSE or ERK inhibitor not only greatly inhibited the increase in CSE level or the phosphorylation of ERK induced by UII but also reversed anti-apoptosis of UII in H2O2-treated-cadiomyocytes. In conclusion, UII rapidly promoted the phosphorylation of ERK and upregulated CSE level and H2S production, which in turn activated ERK signaling to protect cardiomyocytes from apoptosis under oxidative stress. These results suggest that increased plasma UII level may protect cardiomyocytes at the early-phase of acute myocardial infarction in patients.Keywords
Funding Information
- National Natural Science Foundation of China (81370258)
- Science and Technology Commission of Shanghai Municipality (13JC1401703)
This publication has 53 references indexed in Scilit:
- ERK/PP1a/PLB/SERCA2a and JNK Pathways Are Involved in Luteolin-Mediated Protection of Rat Hearts and Cardiomyocytes following Ischemia/ReperfusionPLOS ONE, 2013
- Protein phosphorylation involved in the gene expression of the hydrogen sulphide producing enzyme cystathionine γ-lyase in the pancreatic β-cellMolecular and Cellular Endocrinology, 2012
- EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophyBasic Research in Cardiology, 2011
- Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injuryPeptides, 2008
- The role of urotensin II in cardiovascular and renal physiology and diseasesBritish Journal of Pharmacology, 2006
- Two's company, three's a crowd: can H 2 S be the third endogenous gaseous transmitter?The FASEB Journal, 2002
- BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial ApoptosisMolecular Cell, 2001
- Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expressionBlood, 2001
- Insulin Stimulates Production of Nitric Oxide via ERK in Osteoblast CellsBiochemical and Biophysical Research Communications, 2000
- Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in ratsCardiovascular Research, 1998